CDK4 and head and neck squamous cell carcinoma: The present results indicated that p21 inhibited the activity of the CDK2/Rb pathway without disturbing CDK4/6 in HNSCC, and a specific CDK2 inhibitor reduced the proliferation ability of FOXD1-overexpressing cells by affecting the activation status of this pathway.